Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

BISOPROLOL FUMARATE

18 general benefit · 2 not a benefit

Other products in the same Health Canada class (C07A, C07AB) — coverage varies; not interchangeable

  • Acebutolol (Sectral): general benefit, Not a benefit
  • Atenolol (Apo-Atenol): general benefit
  • Metoprolol (Lopresor SR): general benefit, Not a benefit
  • Nebivolol (Bystolic): not a benefit
  • Nadolol (Corgard): general benefit, Not a benefit
  • Propranolol (Inderal-LA): general benefit, Not a benefit

3 more in the class list below

Sandoz Bisoprolol Tablets · DIN 02544245 · 1.25mg · tablet

General benefitMarketed · checked 2026-09-19
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
No interchangeable product listed in the Ontario extract
Sandoz Bisoprolol Tablets · DIN 02544245 Manufacturer: Sandoz Canada Inc.; listing date 2024-10-31 Health Canada: Marketed since 2024-06-11 · brand SANDOZ BISOPROLOL TABLETS · ATC C07AB07 BISOPROLOL · form Tablet · route Oral · ingredients BISOPROLOL FUMARATE 1.25 MG · company Sandoz canada incorporated · schedule Prescription
Check this DIN again · Health Canada product record

Sandoz Bisoprolol Tablets: Formulary list price $0.0152/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0152 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=103278 · Verify on the e-Formulary ↗ (DIN 02544245)

Source record
DIN 02544245: Sandoz Bisoprolol Tablets Raw flags: chronicUseMed=Y, sec3=Y Item: 240400177; group id 277; item number 0572; lccId None; manufacturer id SDZ Source form: Tab; strength: 1.25mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.0152; ministry $0.0152 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02544245 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=103278
Shortage status: resolved shortage (ended 2025-12-05); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02544245
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Sandoz Bisoprolol Tablets · DIN 02544253 · 2.5mg · tablet

General benefitMarketed · checked 2026-09-18
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
No interchangeable product listed in the Ontario extract
Sandoz Bisoprolol Tablets · DIN 02544253 Manufacturer: Sandoz Canada Inc.; listing date 2024-10-31 Health Canada: Marketed since 2024-06-11 · brand SANDOZ BISOPROLOL TABLETS · ATC C07AB07 BISOPROLOL · form Tablet · route Oral · ingredients BISOPROLOL FUMARATE 2.5 MG · company Sandoz canada incorporated · schedule Prescription
Check this DIN again · Health Canada product record

Sandoz Bisoprolol Tablets: Formulary list price $0.0303/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0303 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=103279 · Verify on the e-Formulary ↗ (DIN 02544253)

Source record
DIN 02544253: Sandoz Bisoprolol Tablets Raw flags: chronicUseMed=Y, sec3=Y Item: 240400178; group id 277; item number 0573; lccId None; manufacturer id SDZ Source form: Tab; strength: 2.5mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.0303; ministry $0.0303 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02544253 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=103279
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02544253
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Apo-Bisoprolol · DIN 02256134 · 5mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Apo-Bisoprolol · DIN 02256134 Manufacturer: Apotex Inc.; listing date 2004-11-16 Health Canada: Marketed since 2004-08-10 · brand APO-BISOPROLOL · ATC C07AB07 BISOPROLOL · form Tablet · route Oral · ingredients BISOPROLOL FUMARATE 5 MG · company Apotex inc · schedule Prescription
Check this DIN again · Health Canada product record

Apo-Bisoprolol: Formulary list price $0.0606/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0606 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=74136 · Verify on the e-Formulary ↗ (DIN 02256134)

Source record
DIN 02256134: Apo-Bisoprolol Raw flags: chronicUseMed=Y, sec3=Y Item: 240400157; group id 277; item number 0574; lccId None; manufacturer id APX Source form: Tab; strength: 5mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.0606; ministry $0.0606 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02256134 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=74136
Interchangeable products
Bisoprolol · DIN 02391589 · $0.0606 Bisoprolol Tablets · DIN 02495562 · $0.0606 Jamp Bisoprolol · DIN 02518805 · $0.0606 Mint-Bisoprolol · DIN 02465612 · $0.0606 Monocor · DIN 02241148 · not recorded PRZ-Bisoprolol · DIN 02541394 · $0.0606 Sandoz Bisoprolol Tablets · DIN 02494035 · $0.0606 Teva-Bisoprolol · DIN 02267470 · $0.0606
Shortage status: resolved shortage (ended 2024-07-18); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02256134
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Bisoprolol · DIN 02391589 · 5mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Bisoprolol · DIN 02391589 Manufacturer: Sanis Health Inc.; listing date 2020-11-30 Health Canada: Marketed since 2020-08-27 · brand BISOPROLOL · ATC C07AB07 BISOPROLOL · form Tablet · route Oral · ingredients BISOPROLOL FUMARATE 5 MG · company Sanis health inc · schedule Prescription
Check this DIN again · Health Canada product record

Bisoprolol: Formulary list price $0.0606/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0606 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=87691 · Verify on the e-Formulary ↗ (DIN 02391589)

Source record
DIN 02391589: Bisoprolol Raw flags: chronicUseMed=Y, sec3=Y Item: 240400157; group id 277; item number 0574; lccId None; manufacturer id SAI Source form: Tab; strength: 5mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.0606; ministry $0.0606 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02391589 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=87691
Interchangeable products
Apo-Bisoprolol · DIN 02256134 · $0.0606 Bisoprolol Tablets · DIN 02495562 · $0.0606 Jamp Bisoprolol · DIN 02518805 · $0.0606 Mint-Bisoprolol · DIN 02465612 · $0.0606 Monocor · DIN 02241148 · not recorded PRZ-Bisoprolol · DIN 02541394 · $0.0606 Sandoz Bisoprolol Tablets · DIN 02494035 · $0.0606 Teva-Bisoprolol · DIN 02267470 · $0.0606
Shortage status: resolved shortage (ended 2020-03-26); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02391589
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Bisoprolol Tablets · DIN 02495562 · 5mg · tablet

General benefitMarketed · checked 2026-09-19
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Bisoprolol Tablets · DIN 02495562 Manufacturer: Sivem Pharmaceuticals ULC; listing date 2020-12-18 Health Canada: Marketed since 2024-12-24 · brand BISOPROLOL TABLETS · ATC C07AB07 BISOPROLOL · form Tablet · route Oral · ingredients BISOPROLOL FUMARATE 5 MG · company Sivem pharmaceuticals ulc · schedule Prescription
Check this DIN again · Health Canada product record

Bisoprolol Tablets: Formulary list price $0.0606/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0606 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=98546 · Verify on the e-Formulary ↗ (DIN 02495562)

Source record
DIN 02495562: Bisoprolol Tablets Raw flags: chronicUseMed=Y, sec3=Y Item: 240400157; group id 277; item number 0574; lccId None; manufacturer id SIV Source form: Tab; strength: 5mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.0606; ministry $0.0606 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02495562 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=98546
Interchangeable products
Apo-Bisoprolol · DIN 02256134 · $0.0606 Bisoprolol · DIN 02391589 · $0.0606 Jamp Bisoprolol · DIN 02518805 · $0.0606 Mint-Bisoprolol · DIN 02465612 · $0.0606 Monocor · DIN 02241148 · not recorded PRZ-Bisoprolol · DIN 02541394 · $0.0606 Sandoz Bisoprolol Tablets · DIN 02494035 · $0.0606 Teva-Bisoprolol · DIN 02267470 · $0.0606
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02495562
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Jamp Bisoprolol · DIN 02518805 · 5mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Jamp Bisoprolol · DIN 02518805 Manufacturer: Jamp Pharma Corporation; listing date 2022-05-31 Health Canada: Marketed since 2022-03-18 · brand JAMP BISOPROLOL · ATC C07AB07 BISOPROLOL · form Tablet · route Oral · ingredients BISOPROLOL FUMARATE 5 MG · company Jamp pharma corporation · schedule Prescription
Check this DIN again · Health Canada product record

Jamp Bisoprolol: Formulary list price $0.0606/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0606 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=100810 · Verify on the e-Formulary ↗ (DIN 02518805)

Source record
DIN 02518805: Jamp Bisoprolol Raw flags: chronicUseMed=Y, sec3=Y Item: 240400157; group id 277; item number 0574; lccId None; manufacturer id JPC Source form: Tab; strength: 5mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.0606; ministry $0.0606 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02518805 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=100810
Interchangeable products
Apo-Bisoprolol · DIN 02256134 · $0.0606 Bisoprolol · DIN 02391589 · $0.0606 Bisoprolol Tablets · DIN 02495562 · $0.0606 Mint-Bisoprolol · DIN 02465612 · $0.0606 Monocor · DIN 02241148 · not recorded PRZ-Bisoprolol · DIN 02541394 · $0.0606 Sandoz Bisoprolol Tablets · DIN 02494035 · $0.0606 Teva-Bisoprolol · DIN 02267470 · $0.0606
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02518805
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Mint-Bisoprolol · DIN 02465612 · 5mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Mint-Bisoprolol · DIN 02465612 Manufacturer: Mint Pharmaceuticals Inc.; listing date 2019-03-28 Health Canada: Marketed since 2019-02-05 · brand MINT-BISOPROLOL · ATC C07AB07 BISOPROLOL · form Tablet · route Oral · ingredients BISOPROLOL FUMARATE 5 MG · company Mint pharmaceuticals inc · schedule Prescription
Check this DIN again · Health Canada product record

Mint-Bisoprolol: Formulary list price $0.0606/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0606 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=95384 · Verify on the e-Formulary ↗ (DIN 02465612)

Source record
DIN 02465612: Mint-Bisoprolol Raw flags: chronicUseMed=Y, sec3=Y Item: 240400157; group id 277; item number 0574; lccId None; manufacturer id MIN Source form: Tab; strength: 5mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.0606; ministry $0.0606 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02465612 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=95384
Interchangeable products
Apo-Bisoprolol · DIN 02256134 · $0.0606 Bisoprolol · DIN 02391589 · $0.0606 Bisoprolol Tablets · DIN 02495562 · $0.0606 Jamp Bisoprolol · DIN 02518805 · $0.0606 Monocor · DIN 02241148 · not recorded PRZ-Bisoprolol · DIN 02541394 · $0.0606 Sandoz Bisoprolol Tablets · DIN 02494035 · $0.0606 Teva-Bisoprolol · DIN 02267470 · $0.0606
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02465612
Shortage record checked 2026-09-13T08:10:21.292534+00:00

PRZ-Bisoprolol · DIN 02541394 · 5mg · tablet

General benefitMarketed · checked 2026-09-19
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
PRZ-Bisoprolol · DIN 02541394 Manufacturer: Pharmaris Canada Inc.; listing date 2026-02-27 Health Canada: Marketed since 2025-11-25 · brand PRZ-BISOPROLOL · ATC C07AB07 BISOPROLOL · form Tablet · route Oral · ingredients BISOPROLOL FUMARATE 5 MG · company Pharmaris canada inc · schedule Prescription
Check this DIN again · Health Canada product record

PRZ-Bisoprolol: Formulary list price $0.0606/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0606 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=103004 · Verify on the e-Formulary ↗ (DIN 02541394)

Source record
DIN 02541394: PRZ-Bisoprolol Raw flags: chronicUseMed=Y, sec3=Y Item: 240400157; group id 277; item number 0574; lccId None; manufacturer id PRZ Source form: Tab; strength: 5mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.0606; ministry $0.0606 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02541394 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=103004
Interchangeable products
Apo-Bisoprolol · DIN 02256134 · $0.0606 Bisoprolol · DIN 02391589 · $0.0606 Bisoprolol Tablets · DIN 02495562 · $0.0606 Jamp Bisoprolol · DIN 02518805 · $0.0606 Mint-Bisoprolol · DIN 02465612 · $0.0606 Monocor · DIN 02241148 · not recorded Sandoz Bisoprolol Tablets · DIN 02494035 · $0.0606 Teva-Bisoprolol · DIN 02267470 · $0.0606
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02541394
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Sandoz Bisoprolol Tablets · DIN 02494035 · 5mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Sandoz Bisoprolol Tablets · DIN 02494035 Manufacturer: Sandoz Canada Inc.; listing date 2020-06-30 Health Canada: Marketed since 2019-11-27 · brand SANDOZ BISOPROLOL TABLETS · ATC C07AB07 BISOPROLOL · form Tablet · route Oral · ingredients BISOPROLOL FUMARATE 5 MG · company Sandoz canada incorporated · schedule Prescription
Check this DIN again · Health Canada product record

Sandoz Bisoprolol Tablets: Formulary list price $0.0606/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0606 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=98405 · Verify on the e-Formulary ↗ (DIN 02494035)

Source record
DIN 02494035: Sandoz Bisoprolol Tablets Raw flags: chronicUseMed=Y, sec3=Y Item: 240400157; group id 277; item number 0574; lccId None; manufacturer id SDZ Source form: Tab; strength: 5mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.0606; ministry $0.0606 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02494035 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=98405
Interchangeable products
Apo-Bisoprolol · DIN 02256134 · $0.0606 Bisoprolol · DIN 02391589 · $0.0606 Bisoprolol Tablets · DIN 02495562 · $0.0606 Jamp Bisoprolol · DIN 02518805 · $0.0606 Mint-Bisoprolol · DIN 02465612 · $0.0606 Monocor · DIN 02241148 · not recorded PRZ-Bisoprolol · DIN 02541394 · $0.0606 Teva-Bisoprolol · DIN 02267470 · $0.0606
Shortage status: resolved shortage (ended 2024-06-12); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02494035
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Teva-Bisoprolol · DIN 02267470 · 5mg · tablet

General benefitMarketed · checked 2026-09-19
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Teva-Bisoprolol · DIN 02267470 Manufacturer: Teva Canada Limited; listing date 2005-08-19 Health Canada: Marketed since 2013-12-17 · brand TEVA-BISOPROLOL · ATC C07AB07 BISOPROLOL · form Tablet · route Oral · ingredients BISOPROLOL FUMARATE 5 MG · company Teva canada limited · schedule Prescription
Check this DIN again · Health Canada product record

Teva-Bisoprolol: Formulary list price $0.0606/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0606 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=75288 · Verify on the e-Formulary ↗ (DIN 02267470)

Source record
DIN 02267470: Teva-Bisoprolol Raw flags: chronicUseMed=Y, sec3=Y Item: 240400157; group id 277; item number 0574; lccId None; manufacturer id TEV Source form: Tab; strength: 5mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.0606; ministry $0.0606 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02267470 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=75288
Interchangeable products
Apo-Bisoprolol · DIN 02256134 · $0.0606 Bisoprolol · DIN 02391589 · $0.0606 Bisoprolol Tablets · DIN 02495562 · $0.0606 Jamp Bisoprolol · DIN 02518805 · $0.0606 Mint-Bisoprolol · DIN 02465612 · $0.0606 Monocor · DIN 02241148 · not recorded PRZ-Bisoprolol · DIN 02541394 · $0.0606 Sandoz Bisoprolol Tablets · DIN 02494035 · $0.0606
Shortage status: resolved shortage (ended 2026-03-25); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02267470
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Apo-Bisoprolol · DIN 02256177 · 10mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Apo-Bisoprolol · DIN 02256177 Manufacturer: Apotex Inc.; listing date 2004-11-16 Health Canada: Marketed since 2004-08-10 · brand APO-BISOPROLOL · ATC C07AB07 BISOPROLOL · form Tablet · route Oral · ingredients BISOPROLOL FUMARATE 10 MG · company Apotex inc · schedule Prescription
Check this DIN again · Health Canada product record

Apo-Bisoprolol: Formulary list price $0.0885/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0885 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=74140 · Verify on the e-Formulary ↗ (DIN 02256177)

Source record
DIN 02256177: Apo-Bisoprolol Raw flags: chronicUseMed=Y, sec3=Y Item: 240400158; group id 277; item number 0575; lccId None; manufacturer id APX Source form: Tab; strength: 10mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.0885; ministry $0.0885 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02256177 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=74140
Interchangeable products
Bisoprolol · DIN 02391597 · $0.0885 Bisoprolol Tablets · DIN 02495570 · $0.0885 Jamp Bisoprolol · DIN 02518791 · $0.0885 Mint-Bisoprolol · DIN 02465620 · $0.0885 Monocor · DIN 02241149 · not recorded PRZ-Bisoprolol · DIN 02541408 · $0.0885 Sandoz Bisoprolol Tablets · DIN 02494043 · $0.0885 Teva-Bisoprolol · DIN 02267489 · $0.0885
Shortage status: resolved shortage (ended 2026-04-02); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02256177
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Bisoprolol · DIN 02391597 · 10mg · tablet

General benefitMarketed · checked 2026-09-19
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Bisoprolol · DIN 02391597 Manufacturer: Sanis Health Inc.; listing date 2020-11-30 Health Canada: Marketed since 2020-08-27 · brand BISOPROLOL · ATC C07AB07 BISOPROLOL · form Tablet · route Oral · ingredients BISOPROLOL FUMARATE 10 MG · company Sanis health inc · schedule Prescription
Check this DIN again · Health Canada product record

Bisoprolol: Formulary list price $0.0885/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0885 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=87692 · Verify on the e-Formulary ↗ (DIN 02391597)

Source record
DIN 02391597: Bisoprolol Raw flags: chronicUseMed=Y, sec3=Y Item: 240400158; group id 277; item number 0575; lccId None; manufacturer id SAI Source form: Tab; strength: 10mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.0885; ministry $0.0885 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02391597 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=87692
Interchangeable products
Apo-Bisoprolol · DIN 02256177 · $0.0885 Bisoprolol Tablets · DIN 02495570 · $0.0885 Jamp Bisoprolol · DIN 02518791 · $0.0885 Mint-Bisoprolol · DIN 02465620 · $0.0885 Monocor · DIN 02241149 · not recorded PRZ-Bisoprolol · DIN 02541408 · $0.0885 Sandoz Bisoprolol Tablets · DIN 02494043 · $0.0885 Teva-Bisoprolol · DIN 02267489 · $0.0885
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02391597
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Bisoprolol Tablets · DIN 02495570 · 10mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Bisoprolol Tablets · DIN 02495570 Manufacturer: Sivem Pharmaceuticals ULC; listing date 2020-12-18 Health Canada: Marketed since 2024-12-24 · brand BISOPROLOL TABLETS · ATC C07AB07 BISOPROLOL · form Tablet · route Oral · ingredients BISOPROLOL FUMARATE 10 MG · company Sivem pharmaceuticals ulc · schedule Prescription
Check this DIN again · Health Canada product record

Bisoprolol Tablets: Formulary list price $0.0885/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0885 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=98547 · Verify on the e-Formulary ↗ (DIN 02495570)

Source record
DIN 02495570: Bisoprolol Tablets Raw flags: chronicUseMed=Y, sec3=Y Item: 240400158; group id 277; item number 0575; lccId None; manufacturer id SIV Source form: Tab; strength: 10mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.0885; ministry $0.0885 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02495570 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=98547
Interchangeable products
Apo-Bisoprolol · DIN 02256177 · $0.0885 Bisoprolol · DIN 02391597 · $0.0885 Jamp Bisoprolol · DIN 02518791 · $0.0885 Mint-Bisoprolol · DIN 02465620 · $0.0885 Monocor · DIN 02241149 · not recorded PRZ-Bisoprolol · DIN 02541408 · $0.0885 Sandoz Bisoprolol Tablets · DIN 02494043 · $0.0885 Teva-Bisoprolol · DIN 02267489 · $0.0885
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02495570
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Jamp Bisoprolol · DIN 02518791 · 10mg · tablet

General benefitMarketed · checked 2026-09-18
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Jamp Bisoprolol · DIN 02518791 Manufacturer: Jamp Pharma Corporation; listing date 2022-05-31 Health Canada: Marketed since 2022-03-18 · brand JAMP BISOPROLOL · ATC C07AB07 BISOPROLOL · form Tablet · route Oral · ingredients BISOPROLOL FUMARATE 10 MG · company Jamp pharma corporation · schedule Prescription
Check this DIN again · Health Canada product record

Jamp Bisoprolol: Formulary list price $0.0885/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0885 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=100809 · Verify on the e-Formulary ↗ (DIN 02518791)

Source record
DIN 02518791: Jamp Bisoprolol Raw flags: chronicUseMed=Y, sec3=Y Item: 240400158; group id 277; item number 0575; lccId None; manufacturer id JPC Source form: Tab; strength: 10mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.0885; ministry $0.0885 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02518791 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=100809
Interchangeable products
Apo-Bisoprolol · DIN 02256177 · $0.0885 Bisoprolol · DIN 02391597 · $0.0885 Bisoprolol Tablets · DIN 02495570 · $0.0885 Mint-Bisoprolol · DIN 02465620 · $0.0885 Monocor · DIN 02241149 · not recorded PRZ-Bisoprolol · DIN 02541408 · $0.0885 Sandoz Bisoprolol Tablets · DIN 02494043 · $0.0885 Teva-Bisoprolol · DIN 02267489 · $0.0885
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02518791
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Mint-Bisoprolol · DIN 02465620 · 10mg · tablet

General benefitMarketed · checked 2026-09-18
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Mint-Bisoprolol · DIN 02465620 Manufacturer: Mint Pharmaceuticals Inc.; listing date 2019-03-28 Health Canada: Marketed since 2019-02-05 · brand MINT-BISOPROLOL · ATC C07AB07 BISOPROLOL · form Tablet · route Oral · ingredients BISOPROLOL FUMARATE 10 MG · company Mint pharmaceuticals inc · schedule Prescription
Check this DIN again · Health Canada product record

Mint-Bisoprolol: Formulary list price $0.0885/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0885 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=95385 · Verify on the e-Formulary ↗ (DIN 02465620)

Source record
DIN 02465620: Mint-Bisoprolol Raw flags: chronicUseMed=Y, sec3=Y Item: 240400158; group id 277; item number 0575; lccId None; manufacturer id MIN Source form: Tab; strength: 10mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.0885; ministry $0.0885 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02465620 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=95385
Interchangeable products
Apo-Bisoprolol · DIN 02256177 · $0.0885 Bisoprolol · DIN 02391597 · $0.0885 Bisoprolol Tablets · DIN 02495570 · $0.0885 Jamp Bisoprolol · DIN 02518791 · $0.0885 Monocor · DIN 02241149 · not recorded PRZ-Bisoprolol · DIN 02541408 · $0.0885 Sandoz Bisoprolol Tablets · DIN 02494043 · $0.0885 Teva-Bisoprolol · DIN 02267489 · $0.0885
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02465620
Shortage record checked 2026-09-13T08:10:21.292534+00:00

PRZ-Bisoprolol · DIN 02541408 · 10mg · tablet

General benefitMarketed · checked 2026-09-18
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
PRZ-Bisoprolol · DIN 02541408 Manufacturer: Pharmaris Canada Inc.; listing date 2026-02-27 Health Canada: Marketed since 2025-11-25 · brand PRZ-BISOPROLOL · ATC C07AB07 BISOPROLOL · form Tablet · route Oral · ingredients BISOPROLOL FUMARATE 10 MG · company Pharmaris canada inc · schedule Prescription
Check this DIN again · Health Canada product record

PRZ-Bisoprolol: Formulary list price $0.0885/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0885 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=103006 · Verify on the e-Formulary ↗ (DIN 02541408)

Source record
DIN 02541408: PRZ-Bisoprolol Raw flags: chronicUseMed=Y, sec3=Y Item: 240400158; group id 277; item number 0575; lccId None; manufacturer id PRZ Source form: Tab; strength: 10mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.0885; ministry $0.0885 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02541408 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=103006
Interchangeable products
Apo-Bisoprolol · DIN 02256177 · $0.0885 Bisoprolol · DIN 02391597 · $0.0885 Bisoprolol Tablets · DIN 02495570 · $0.0885 Jamp Bisoprolol · DIN 02518791 · $0.0885 Mint-Bisoprolol · DIN 02465620 · $0.0885 Monocor · DIN 02241149 · not recorded Sandoz Bisoprolol Tablets · DIN 02494043 · $0.0885 Teva-Bisoprolol · DIN 02267489 · $0.0885
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02541408
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Sandoz Bisoprolol Tablets · DIN 02494043 · 10mg · tablet

General benefitMarketed · checked 2026-09-19
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Sandoz Bisoprolol Tablets · DIN 02494043 Manufacturer: Sandoz Canada Inc.; listing date 2020-06-30 Health Canada: Marketed since 2019-11-27 · brand SANDOZ BISOPROLOL TABLETS · ATC C07AB07 BISOPROLOL · form Tablet · route Oral · ingredients BISOPROLOL FUMARATE 10 MG · company Sandoz canada incorporated · schedule Prescription
Check this DIN again · Health Canada product record

Sandoz Bisoprolol Tablets: Formulary list price $0.0885/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0885 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=98406 · Verify on the e-Formulary ↗ (DIN 02494043)

Source record
DIN 02494043: Sandoz Bisoprolol Tablets Raw flags: chronicUseMed=Y, sec3=Y Item: 240400158; group id 277; item number 0575; lccId None; manufacturer id SDZ Source form: Tab; strength: 10mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.0885; ministry $0.0885 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02494043 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=98406
Interchangeable products
Apo-Bisoprolol · DIN 02256177 · $0.0885 Bisoprolol · DIN 02391597 · $0.0885 Bisoprolol Tablets · DIN 02495570 · $0.0885 Jamp Bisoprolol · DIN 02518791 · $0.0885 Mint-Bisoprolol · DIN 02465620 · $0.0885 Monocor · DIN 02241149 · not recorded PRZ-Bisoprolol · DIN 02541408 · $0.0885 Teva-Bisoprolol · DIN 02267489 · $0.0885
Shortage status: resolved shortage (ended 2023-02-08); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02494043
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Teva-Bisoprolol · DIN 02267489 · 10mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Teva-Bisoprolol · DIN 02267489 Manufacturer: Teva Canada Limited; listing date 2005-08-19 Health Canada: Marketed since 2013-12-17 · brand TEVA-BISOPROLOL · ATC C07AB07 BISOPROLOL · form Tablet · route Oral · ingredients BISOPROLOL FUMARATE 10 MG · company Teva canada limited · schedule Prescription
Check this DIN again · Health Canada product record

Teva-Bisoprolol: Formulary list price $0.0885/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0885 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=75289 · Verify on the e-Formulary ↗ (DIN 02267489)

Source record
DIN 02267489: Teva-Bisoprolol Raw flags: chronicUseMed=Y, sec3=Y Item: 240400158; group id 277; item number 0575; lccId None; manufacturer id TEV Source form: Tab; strength: 10mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.0885; ministry $0.0885 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02267489 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=75289
Interchangeable products
Apo-Bisoprolol · DIN 02256177 · $0.0885 Bisoprolol · DIN 02391597 · $0.0885 Bisoprolol Tablets · DIN 02495570 · $0.0885 Jamp Bisoprolol · DIN 02518791 · $0.0885 Mint-Bisoprolol · DIN 02465620 · $0.0885 Monocor · DIN 02241149 · not recorded PRZ-Bisoprolol · DIN 02541408 · $0.0885 Sandoz Bisoprolol Tablets · DIN 02494043 · $0.0885
Shortage status: resolved shortage (ended 2026-04-15); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02267489
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Monocor · DIN 02241148 · 5mg · tablet

Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2009-07-31 — choose a marketed DIN from the same-category list.Discontinued 2009-07-31 · checked 2026-09-19
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2009-07-31 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives; Health Canada lists this DIN as Cancelled post market since 2009-07-31 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Monocor · DIN 02241148 Manufacturer: Biovail Pharmaceuticals Canada; listing date 2001-06-07 Health Canada: Cancelled post market since 2009-07-31 · brand MONOCOR -(5MG) · ATC C07AB07 BISOPROLOL · form Tablet · route Oral · ingredients BISOPROLOL FUMARATE 5 MG · company Biovail pharmaceuticals canada division of biovail corporation · schedule Prescription
Check this DIN again · Health Canada product record

Monocor: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=64754 · Verify on the e-Formulary ↗ (DIN 02241148)

Source record
DIN 02241148: Monocor Raw flags: chronicUseMed=Y, notABenefit=Y, sec3=Y Item: 240400157; group id 277; item number 0574; lccId None; manufacturer id BIO Source form: Tab; strength: 5mg Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02241148 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=64754
Interchangeable products
Apo-Bisoprolol · DIN 02256134 · $0.0606 Bisoprolol · DIN 02391589 · $0.0606 Bisoprolol Tablets · DIN 02495562 · $0.0606 Jamp Bisoprolol · DIN 02518805 · $0.0606 Mint-Bisoprolol · DIN 02465612 · $0.0606 PRZ-Bisoprolol · DIN 02541394 · $0.0606 Sandoz Bisoprolol Tablets · DIN 02494035 · $0.0606 Teva-Bisoprolol · DIN 02267470 · $0.0606
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02241148
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2009-07-31 — choose a marketed DIN from the same-category list.

Monocor · DIN 02241149 · 10mg · tablet

Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2005-03-10 — choose a marketed DIN from the same-category list.Discontinued 2005-03-10 · checked 2026-09-02
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2005-03-10 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives; Health Canada lists this DIN as Cancelled post market since 2005-03-10 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Monocor · DIN 02241149 Manufacturer: Crystaal Corp.; listing date 2001-06-07 Health Canada: Cancelled post market since 2005-03-10 · brand MONOCOR -(10MG) · ATC C07AB07 BISOPROLOL · form Tablet · route Oral · ingredients BISOPROLOL FUMARATE 10 MG · company Biovail pharmaceuticals canada division of biovail corporation · schedule Prescription
Check this DIN again · Health Canada product record

Monocor: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=64755 · Verify on the e-Formulary ↗ (DIN 02241149)

Source record
DIN 02241149: Monocor Raw flags: chronicUseMed=Y, notABenefit=Y, sec3=Y Item: 240400158; group id 277; item number 0575; lccId None; manufacturer id CRY Source form: Tab; strength: 10mg Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02241149 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=64755
Interchangeable products
Apo-Bisoprolol · DIN 02256177 · $0.0885 Bisoprolol · DIN 02391597 · $0.0885 Bisoprolol Tablets · DIN 02495570 · $0.0885 Jamp Bisoprolol · DIN 02518791 · $0.0885 Mint-Bisoprolol · DIN 02465620 · $0.0885 PRZ-Bisoprolol · DIN 02541408 · $0.0885 Sandoz Bisoprolol Tablets · DIN 02494043 · $0.0885 Teva-Bisoprolol · DIN 02267489 · $0.0885
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02241149
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2005-03-10 — choose a marketed DIN from the same-category list.
Other drugs in the same formulary class (24:04 Cardiac Drugs) and how they are covered

Matched class: 24:04 Cardiac Drugs

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: ATENOLOL, DIGOXIN, PROPAFENONE HCL Some products covered without a code (check the product listing): ACEBUTOLOL HCL, AMIODARONE HCL, AMLODIPINE, DILTIAZEM HCL, DISOPYRAMIDE, FLECAINIDE ACETATE, METOPROLOL TARTRATE, MEXILETINE HCL, NADOLOL, NIFEDIPINE, PROPRANOLOL, SOTALOL HCL, TIMOLOL MALEATE, VERAPAMIL HCL 24:00 CARDIOVASCULAR DRUGS

RANOLAZINE

· 2 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 500mg · ER Tab Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 24:00 24:04 Cardiac Drugs

ACEBUTOLOL HCL

· 9 products · Listed, not a benefit (3), General benefit (6) · strengths: 100mg, 200mg, 400mg · Tab

ATENOLOL

· 26 products · General benefit · strengths: 50mg, 100mg · Tab

METOPROLOL TARTRATE

· 28 products · Listed, not a benefit (6), General benefit (22) · strengths: 100mg, 200mg, 50mg · LA Tab, Tab

NEBIVOLOL HYDROCHLORIDE

· 8 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 2.5mg, 5mg, 10mg, 20mg · Tab

NADOLOL

· 8 products · Listed, not a benefit (3), General benefit (5) · strengths: 40mg, 80mg, 160mg · Tab

PROPRANOLOL

· 19 products · Off-Formulary Interchangeable, not an ODB benefit (8), General benefit (7), Listed, not a benefit (4) · strengths: 60mg, 80mg, 120mg, 160mg, 10mg, 20mg, 40mg · LA Cap, Tab

SOTALOL HCL

· 10 products · Listed, not a benefit (2), General benefit (8) · strengths: 80mg, 160mg · Tab

TIMOLOL MALEATE

· 6 products · Listed, not a benefit (3), General benefit (3) · strengths: 5mg, 10mg, 20mg · Tab

CARVEDILOL

· 36 products · Listed, not a benefit (4), Limited Use, codes 183 (32) · strengths: 3.125mg, 6.25mg, 12.5mg, 25mg · Tab

AMIODARONE HCL

· 9 products · Listed, not a benefit (1), General benefit (8) · strengths: 200mg · Tab

AMLODIPINE

· 56 products · Limited Use, codes 645, 706 (1), Off-Formulary Interchangeable, not an ODB benefit (11), General benefit (44) · strengths: 1mg/mL, 2.5mg, 5mg, 10mg · Oral Sol, Tab Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 24:04 and 9 more
Full class listing Related classes: 24:06 Antilipemic Drugs, 24:08 Hypotensive Drugs (For Diuretics See 40:28), 24:12 Vasodilating Drugs, 24:32 Renin-Angiotensin Aldosterone Inhibitors Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
INDICATIONS AND CLINICAL USE APO-BISOPROLOL (bisoprolol fumarate) is indicated in the management of patients with mild to moderate hypertension. It may be used alone or in combination with other antihypertensive agents, particularly thiazide diuretics. APO-BISOPROLOL is not recommended for the emergency treatment of hypertensive crisis. https://pdf.hres.ca/dpd_pm/00084194.PDF PM date: APR 08, 2026 Source product: APO-BISOPROLOL; DIN 02256134; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.

Other review policies

For Monocor: no applicable EAP criteria are held and no ODB benefit is established. These policies do not establish coverage.

For rare, immediately life-, limb- or organ-threatening circumstances, the Compassionate Review Policy may consider an unfunded drug or indication, subject to its criteria and without bypassing the drug review process. Compassionate Review Policy

Compassionate Review Policy: source quote
Where there are rare clinical circumstances in immediately life, limb, or organ-threatening conditions, the Executive Officer will also consider requests for drugs or indications in situations where there has not been a decision by the Executive Officer to provide funding of the drug or indication as part of the Ontario Drug Benefit program (and the EAP), and the drug or indication requested would not circumvent the established review process for new drugs or indications as part of the drug submission process for listing within the Ontario Drug Benefit program. Requests must meet the criteria for the Compassionate Review Policy.

Ontario source; updated September 15, 2026

For cancer drugs, Case-by-Case Review considers rare, immediately life-threatening circumstances when no satisfactory funded treatment exists; its criteria and application process apply. Case-by-Case Review (cancer drugs)

Case-by-Case Review (cancer drugs): source quote
Note: Requests for cancer drugs are considered under the Case-by-Case Review Program (CBCRP) which is administered by Ontario Health (Cancer Care Ontario) on behalf of the Ministry of Health. The CBCRP considers funding requests for drugs (both oral therapies and injectable drugs) for the treatment of cancer in patients who have a rare clinical circumstance that is immediately life-threatening (death is likely within a matter of months) and who require treatment with an unfunded drug, because there is no other satisfactory and funded treatment. Please refer to the Ontario Health website for information on the application process, FAQs, eligibility criteria and program policies.

Ontario source; updated September 15, 2026